- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
News Release
The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The NIH Researching COVID to Enhance Recovery (RECOVER) Initiative made the parent award to New York University (NYU) Langone Health, New York City,...
Showing 10 out of 2007 results
|
NHLBI in the Press
A small study found that young adults with heritable forms of hypertrophic cardiomyopathy who received valsartan, a drug used to treat high blood pressure and heart failure, tolerated the treatment and were less likely to experience changes in cardiovascular structure and function.
|
Media Advisory
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has announced April P. Carson, Ph.D., as the new director of the Jackson Heart Study (JHS). The JHS is the nation’s largest and longest-running longitudinal study of cardiovascular health in African Americans, involving more than 5,300 participants in...
|
News Release
The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The NIH Researching COVID to Enhance Recovery (RECOVER) Initiative made the parent award to New York University (NYU) Langone Health, New York City,...
|
NHLBI in the Press
Adults with normal blood pressure and high levels of stress hormones are more likely to develop high blood pressure and experience cardiovascular events, study says.
|
NHLBI in the Press
After studying lung infection rates among New York City firefighters who served as first responders at the World Trade Center on Sept. 11, 2001 and were exposed to tiny air pollution particles, researchers identified factors that overlapped with lung infection risks.
|
Research Feature
When COVID-19 restrictions closed research laboratories across the country, it meant Erik Kimble, M.D.’s hematology and oncology training came to a virtual crawl. Not surprisingly, Kimble, who completed medical school in Mexico at the height of the swine flu pandemic, was overwhelmed yet again with uncertainty. He spent months preparing for his...
|
NHLBI in the Press
A phase 3 trial found using colchicine reduced death and hospitalization rates among adults with COVID-19 recovering at home, but only if they had a positive test result. More research is necessary to assess the benefits of using this anti-inflammatory treatment for moderate COVID-19 cases.
|
NHLBI in the Press
Moving more and sitting less were factors associated with a reduced likelihood of developing obstructive sleep apnea among thousands of health care providers.
|
NHLBI in the Press
Lung ultrasound did not help emergency departments (EDs) manage acute heart failure patients in their initial hours of presenting with symptoms, according to the findings of a randomized pilot trial.
Credit: NIH Image Gallery
|
NHLBI in the Press
A phase 2 study with 59 patients found fostamatinib, a targeted immune therapy used for a rare bleeding disorder, did not result in more adverse outcomes among adults hospitalized for COVID-19 who required assisted breathing support.